Symmetric Dimethylarginine Modification Drives Shared and Divergent Antigen Reactivity in Lupus
Liu, P.; Li, H.; Wei, A. Z.-S.; Park, J. G.; Lu, W.; Xie, X.; Jin, J.
Show abstract
Systemic lupus erythematosus (SLE) features a broad array of autoantibodies against nuclear components, but the mechanisms driving this diversity are poorly understood. We investigated whether posttranslational arginine methylation creates common neo-epitopes that could unify this response. Using methylome-wide peptide arrays, we identified anti-symmetric dimethylarginine (SDMA) autoantibodies in 30-40% of SLE patients, with individualized reactivity fingerprints. A single anti-SDMA monoclonal antibody from MRL-lpr mice recognized multiple SDMA-modified antigens, and EBNA-1, an Epstein-Barr virus protein, bound SLE plasma in an SDMA-dependent manner, pointing to potential molecular mimicry. In a validation cohort of 201 patients, anti-SDMA titers correlated with SLEDAI-2K scores and inversely with C3/C4; seropositivity was overrepresented in younger patients, those with renal involvement, and anti-Sm-positive individuals. These results establish that anti-SDMA responses are common in SLE, target methylated arginine motifs across self and viral proteins, and serve as markers of active, complement-consuming disease. The patient-specific recognition of SDMA epitopes may underlie the serological heterogeneity that defines SLE.
Matching journals
The top 7 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Plasmacytoid dendritic cells are functionally exhausted while non-haematopoietic sources of type I interferon dominate human autoimmunity 96%
- Single-cell transcriptomics identifies drivers of local inflammation in multiple sclerosis 94%
- SLE non-coding Genetic Risk Variant Determines the Epigenetic Dysfunction of an Immune Cell Specific Enhancer that Controls Disease-critical microRNA Expression 93%
Similar papers in this journal
Similar papers in this journal
Similar papers in this journal
- Patient ancestry significantly contributes to molecular heterogeneity of systemic lupus erythematosus. 95%
- Mapping the plasma proteomic architecture of systemic lupus erythematosus 95%
- Single cell transcriptomics reveals distinct effector profiles of infiltrating T cells in lupus skin and kidney 93%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.